Abiopharma

CECO Environmental Reports Second Quarter 2026 Results

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency

Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

monday.com Announces Second Quarter 2026 Results

Auddia Announces SEC Effectiveness of S-4 Registration Statement Clearing Major Merger Milestone

Ceva, Inc. Announces Second Quarter 2026 Financial Results

Western Midstream Announces Second-Quarter Post-Earnings Interview with Chief Financial Officer, Kristen Shults and Participation in Upcoming Investor Conferences

Hello Group to Report Second Quarter 2026 Results on September 3, 2026

Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma